What is the level of liabilities of Theraclion this year?
Theraclion has a debt balance of 13.02 M EUR this year.
Theraclion Liabilities 2024
Theraclion Liabilities
13.02 M EUR
Ticker
ALTHE.PA
ISIN
FR0010120402
WKN
A112C8
In 2024, Theraclion's total liabilities amounted to 13.02 M EUR, a -2.85% difference from the 13.4 M EUR total liabilities in the previous year.
Theraclion Aktienanalyse
What does Theraclion do?
Theraclion SA is a French medical company specializing in the development and production of innovative therapy systems. The company was founded in 2004 and is headquartered in Malakoff, France. Theraclion's business model is based on the development and marketing of medical devices based on High Intensity Focused Ultrasound (HIFU) technology. This technology uses ultrasound pulses to treat targeted areas in the body without the need for surgical intervention. Theraclion specializes in three main areas: oncology, dermatology, and aesthetics. In the field of oncology, Theraclion has developed the Echopulse system, which is used for the treatment of breast tumors. The system applies high-intensity ultrasound pulses to kill tumor cells without damaging surrounding tissue. This non-invasive method of tumor treatment is very promising and has already shown promising results in several studies. In the field of dermatology, Theraclion has developed the Echovist system, which is used for the treatment of nevi (moles). The system also utilizes HIFU technology to destroy the nevi, resulting in a significant improvement in the aesthetic appearance of the skin. In the field of aesthetics, Theraclion has developed the Sonovein system, which is used for the treatment of varicose veins. The system also utilizes HIFU technology to close the veins and thus improve the patient's appearance and quality of life. Theraclion has experienced impressive growth in recent years and is now an important player in the medical industry. The company has filed several patents and works closely with leading doctors and research institutions to maximize the effectiveness of its products. Overall, Theraclion aims to offer innovative therapies that meet the needs of patients and help them lead fulfilling lives. The company is committed to continuously improving its products and services and strives to achieve even greater successes in the future. Theraclion ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Theraclion's Liabilities
Theraclion's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Theraclion's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Theraclion's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Theraclion's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Theraclion’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Theraclion stock
What were the liabilities of Theraclion compared to the previous year?
The liabilities of Theraclion have increased by -2.85% dropped compared to the previous year.
What are the consequences of high debt for investors of Theraclion?
High liabilities can pose a risk for investors of Theraclion, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Theraclion?
Low liabilities mean that Theraclion has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Theraclion affect the company?
An increase in liabilities of Theraclion can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Theraclion affect the company?
A decrease in the liabilities of Theraclion can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Theraclion?
Some factors that can influence the liabilities of Theraclion include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Theraclion so important for investors?
The liabilities of Theraclion are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Theraclion take to modify the liabilities?
To change its liabilities, Theraclion can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Theraclion pay?
Over the past 12 months, Theraclion paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Theraclion is expected to pay a dividend of 0 EUR.
What is the dividend yield of Theraclion?
The current dividend yield of Theraclion is .
When does Theraclion pay dividends?
Theraclion pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Theraclion?
Theraclion paid dividends every year for the past 0 years.
What is the dividend of Theraclion?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Theraclion located?
Theraclion is assigned to the 'Health' sector.
Wann musste ich die Aktien von Theraclion kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Theraclion from 11/18/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 11/18/2024.
When did Theraclion pay the last dividend?
The last dividend was paid out on 11/18/2024.
What was the dividend of Theraclion in the year 2023?
In the year 2023, Theraclion distributed 0 EUR as dividends.
In which currency does Theraclion pay out the dividend?
The dividends of Theraclion are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Theraclion
Our stock analysis for Theraclion Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Theraclion Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
